Neuroprotection
Neuroprotection(神经保护)
Neuroprotection 相关产品(114)
- GC49434Tauroursodeoxycholic Acid (sodium salt hydrate)纯度: >95.00%
A taurine-conjugated form of ursodeoxycholic acid
- GC49855Harmalol (hydrochloride hydrate)CAS: 6028-00-8纯度: >98.00%
A β-carboline alkaloid and an active metabolite of harmaline
- GC50192Tomoxetine - d3 hydrochlorideCAS: 1217776-38-9
An internal standard for the quantification of atomoxetine
- GC52100(Arg)9 (trifluoroacetate salt)CAS: 1228255-42-2纯度: >95.00%
A cationic cell-penetrating peptide
- GC52303Ethyl MycophenolateCAS: 32483-51-5纯度: >98.00%
A potential impurity found in commercial preparations of mycophenolate mofetil
- GC52310L-Arginine-13C6 (hydrochloride)CAS: 201740-91-2纯度: >95.00% / >98.50%
An internal standard for the quantification of L-arginine
- GC523243-(3-Hydroxyphenyl)propionic Acid sulfateCAS: 86321-32-6纯度: >95.00%
A metabolite of certain phenols and glycosides
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49426 | Taurine-d4 | 342611-14-7 | >99.00% | |
An internal standard for the quantification of taurine | ||||
| GC49434 | Tauroursodeoxycholic Acid (sodium salt hydrate) | - | >95.00% | |
A taurine-conjugated form of ursodeoxycholic acid | ||||
| GC49493 | IRL 1620 (trifluoroacetate salt) | - | >98.00% | |
A peptide ET B receptor agonist | ||||
| GC49500 | Stobadine | 85202-17-1 | >98.00% | |
A pyridoindole antioxidant | ||||
| GC49556 | Cl-Necrostatin-1 | 862377-51-3 | >95.00% | |
A RIPK1 inhibitor | ||||
| GC49674 | Schizandrin | 7432-28-2 | >97.00% | |
A lignan with diverse biological activities | ||||
| GC49740 | Brevetoxin 3 | 85079-48-7 | >95.00% | |
A neurotoxin | ||||
| GC49855 | Harmalol (hydrochloride hydrate) | 6028-00-8 | >98.00% | |
A β-carboline alkaloid and an active metabolite of harmaline | ||||
| GC49869 | 3-Methoxytyrosine | 7636-26-2 | >95.00% | |
An active metabolite of L-DOPA | ||||
| GC49873 | Protectin D1 methyl ester | 934005-36-4 | >95.00% | |
An esterified form of protectin D1 | ||||
| GC49913 | Davunetide (acetate) | - | >98.00% | |
A neuroprotective ADNP-derived peptide | ||||
| GC50192 | Tomoxetine - d3 hydrochloride | 1217776-38-9 | - | |
An internal standard for the quantification of atomoxetine | ||||
| GC52007 | N-hydroxylamine Dapsone | 32695-27-5 | >98.00% | |
An active metabolite of dapsone | ||||
| GC52100 | (Arg)9 (trifluoroacetate salt) | 1228255-42-2 | >95.00% | |
A cationic cell-penetrating peptide | ||||
| GC52303 | Ethyl Mycophenolate | 32483-51-5 | >98.00% | |
A potential impurity found in commercial preparations of mycophenolate mofetil | ||||
| GC52310 | L-Arginine-13C6 (hydrochloride) | 201740-91-2 | >95.00% / >98.50% | |
An internal standard for the quantification of L-arginine | ||||
| GC52324 | 3-(3-Hydroxyphenyl)propionic Acid sulfate | 86321-32-6 | >95.00% | |
A metabolite of certain phenols and glycosides | ||||
| GC52332 | Arimoclomol | 289893-25-0 | >98.00% | |
A co-inducer of heat shock proteins | ||||
| GC52476 | Bax Inhibitor Peptide V5 (trifluoroacetate salt) | - | >98.00% | |
A Bax inhibitor | ||||
| GC60517 | 4-Hydroxyatomoxetine | 435293-66-6 | - | |
A metabolite of atomoxetine | ||||
| GC60875 | GKT136901 | 955272-06-7 | >99.00% | |
A dual inhibitor of NOX1 and NOX4 | ||||
| GC61286 | SP-8356 | 1454885-45-0 | >99.00% | |
SP-8356, an anti-inflammatory synthetic verbenone derivative, is a CD147 inhibitor with respect to its regulation of breast cancer cell behavior and cancer progression. | ||||
| GC61843 | Mofezolac | 78967-07-4 | >98.50% | |
A COX-1 inhibitor | ||||
| GC70332 | (+)-Erinacin A | 156101-08-5 | >99.00% | |
(+)-Erinacin A是一种抗癌化合物，可以从蘑菇猴头菇中分离出来。 | ||||